Reuters reported that the court did not address the merits of the case, only that a Texas judge was wrong to dismiss it in February. Meanwhile, the Federal Trade Commission has accused the three ...

The owner of one of the three largest pharmacy middlemen in the United States last week filed suit to quash an attempt by the ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

One complicating factor is manufacturer rebates, which are discounts on prescription list prices provided by drug manufacturers to pharmacy benefit managers, which in turn may share some or all of ...

The researchers also note that there could be other unaccounted for factors that affected insulin prices. Further research that explores other factors and includes multiple states could further ...

A recent study by researchers at Shandong University in China found that insulin resistance is linked to an increased risk of several diseases and early death in women. Insulin resistance occurs when ...

MONDAY, Sept. 9, 2024 (HealthDay News) -- Diabetics who fly with an insulin pump could find themselves with lower-than-normal blood sugar levels, a new study says. Altitude appears to affect the ...

Eli Lilly (NYSE:LLY) on Thursday announced that its QWINT-1 and QWINT-3 Phase 3 clinical trials for once-weekly insulin efsitora alfa reached the primary endpoints against daily basal insulins ...

The U.S. Drug Enforcement Administration (DEA) has allowed an increase in Vyvanse production of around 24 percent to help with the ADHD drug shortage nationwide. The DEA greenlighted the spike in ...